There is no doubt that the COVID-19 crisis has devastated the U.S. economy. But the particulars of this devastation are difficult to gauge, because unique aspects of the of the pandemic distort the data commonly used to assess such situations. In this Kenan Insight, we take a deep dive into the data to learn what it actually tells us about the economic impact of COVID-19, and suggest possibilities for a restart and recovery of the U.S. economy.
Following last week’s debate about the overheating economy, Kenan Institute experts return this week for round two – this time focusing on policy. In this week's insight, Kenan Institute’s Executive Director Greg Brown and Chief Economist Gerald Cohen debate the pandemic’s influence on U.S. fiscal policies.
2022 was a tumultuous year: NASDAQ, a tech-heavy stock index, closed the year down more than 30%; inflation proved more stubborn than policymakers initially thought and reached 40-year highs; Russia invaded Ukraine, sending commodity prices even higher; and central banks cranked up rates in response, the Federal Reserve raising interest rates at an unprecedented pace in recent history from around zero to over 4%. As we entered 2023, the global economy stood “on a razor’s edge,” the World Bank warned in its latest projections. Add to that a divided Congress with razor-thin majorities, political wrangling over the debt ceiling, and increasingly frequent catastrophic weather events, and it leaves one wondering where we are all headed.
A February cyberattack targeting Change Healthcare resulted in the most extensive healthcare data breach to date, raising questions about industrywide risk management and regulation.
The COVID-19 pandemic has generated a significant shift in how and where we work, play and live. In this Kenan Insight, we explore which changes will be temporary and which are here to stay.
As the unexpected increasingly becomes part of the everyday, Kenan Institute Distinguished Fellow Kathleen M. Sutcliffe discusses the capabilities and processes that allow businesses to face their moments of truth with resilience.
Despite strong economic indicators—2.5% GDP growth, unemployment under 4%, and easing inflation—American consumer sentiment remains low. Kenan Institute experts explore why the public's mood doesn’t match the upbeat data, highlighting deeper sources of economic unease.
UNC Professor Mohammad Jarrahi and IBM’s Phaedra Boinodiris address concerns about organizational adoption of artificial intelligence and how to include employees in important discussions, such as ethical considerations and potential job-related changes.
Corporate executives have begun to glimpse the strategic value of incorporating artificial intelligence as an “employee” within their organization. In this Kenan Insight, we explore a framework that outlines the critical elements for harnessing the potential of human-AI working relationships.
Don't miss this compelling keynote session by Chloe Hakim-Moore, an internationally acclaimed entrepreneur, a Forbes 30 Under 30 honoree, and TEDx speaker, on April 10, 2025, at 4 PM.
On Jan. 3, 2019, Bristol-Myers Squibb Co. announced its proposed acquisition of Celgene Corp. for approximately $74 billion. The Federal Trade Commission issued requests for additional information and documentary materials to the companies on March 25, 2019, that were “focused on marketed and pipeline products for the treatment of psoriasis.” In order to address the FTC’s concerns, BMS plans to divest Celgene’s Otezla (apremilast) drug, which is a phosphodiesterase-4 inhibitor indicated for the treatment of moderate to severe psoriasis and psoriatic arthritis. Psoriasis is an autoimmune disease with multiple subtypes, with large skin plaques being the most common manifestation.
Hosted by the North Carolina Investment Forum, this invitation-only breakfast will bring together members of the private capital community to launch efforts in compiling a comprehensive analysis of capital availability in North Carolina.
...members of the Triangle’s burgeoning tech ecosystem to learn from leading software executives and their investors about proven approaches to scaling from $10 million to $100 million in annual recurring...
...venenatis tellus in metus vulputate eu scelerisque felis. 12 Oct 2023 Frontiers of Business Conference: Workforce Disrupted Our 2023 Frontiers of Business Conference will convene corporate executives, top researchers and...
Join IBM’s Tim Humphrey and former Domino’s CEO Ritch Allison for “Workplace Talent, Skills and Economic Competitiveness: A Fireside Chat with UNC Kenan-Flagler Dean Mary Margaret Frank” Oct. 12 at The Carolina Inn.
...businesses develop the agility and adaptability to make themselves more resilient? Frontiers of Business Conference: Building Business Resilience October 10, 2024 The Carolina Inn, Chapel Hill, N.C. Watch the 2024...
Join Steve Malik and the Honorable Sarah Bloom Raskin on October 10 at The Carolina Inn for “Risk, Uncertainty and Adaptive Resilience: A Fireside Chat with UNC Kenan-Flagler Dean Mary Margaret Frank."
How do firms try to retain workers in a tight labor market? New research finds that employers use a variety of pay and nonpay mechanisms but that multiplant companies may find the nonpay options more cost-effective.
The COVID-19 pandemic has exposed flaws in the global supply chain that have existed for years, with disruptions that have led to a scarcity of goods as diverse as PPE, food and toilet paper. In this Kenan Insight, we examine how threats to supply chains are forcing companies to rethink how they can position themselves to mitigate future risk.
Background: Influenza imposes heavy societal costs through healthcare expenditures, missed days of work, and numerous hospitalizations each year. Considering these costs, the healthcare and behavioral science literature offers suggestions on increasing demand for flu vaccinations. And yet, the adult flu vaccination rate fluctuated between 37% and 46% between 2010 and 2019.
Aim: Although a demand-side approach represents one viable strategy, an operations management approach would also highlight the need to consider a supply-side approach. In this paper, we investigate how to improve clinic vaccination rates by altering provider behavior.